Laboratory Corporation of Ameri Price Today
Laboratory Corporation of Ameri
LH
Healthcare
$16.89B
💰
Market Cap
27.9
💸
Price to Earnings
$7.1
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
11 |
Strong Buy |
7 |
Hold |
6 |
Sell |
0 |
Strong Sell |
0 |
LH Price Forecast Target
199.0 👉 270.0 +36%
LH EPS Forecast
7.1 👉 14.7 +105%
Financials
Profit Margin
4 %
Revenue Growth
-15.2 %
Dividend
$ 2.88
Held Percent
0.3% - Insiders
93.3% - Institutions
6.4% - Public
Major Fund Holders
-
💰 Blackrock Inc. $3.1B
-
💰 Vanguard Group Inc $2.5B
-
💰 State Street Corporation $948.6M
-
💰 Wellington Management Group, LLP $497.7M
-
💰 Geode Capital Management, LLC $452.8M
Stock Ideas
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, Ch…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…📮FAQ
Some Frequently Asked Questions.
The Laboratory Corporation of Ameri industry is Diagnostics & Research
The Laboratory Corporation of Ameri sector is Healthcare
The Laboratory Corporation of Ameri forecasted predicted Price to Earnings PE ratio is 13.6
The Laboratory Corporation of Ameri Price to Earnings PE ratio is 27.9
The Market Capitalization of Laboratory Corporation of Ameri is $16.89B
There are total of 84596907 float shares with 93.3% held by Institutions and 0.3% held by insiders
The MLaboratory Corporation of Ameri forecasted Earnings per Share EPS is $14.7
The Laboratory Corporation of Ameri Earnings per Share EPS is 7.1
The Laboratory Corporation of Ameri company has $4385100000 gross profits with 4 profit margins
The Laboratory Corporation of Ameri Earnings Growth is -0.459% with -0.48% quarterly earnings growth
The Laboratory Corporation of Ameri Revenue is $15070900224 with -0.152 revenue growth
The price target for Laboratory Corporation of Ameri stock is $270.0 for the high target and $210.0 for the low target
The consensus analyst recommendations for Laboratory Corporation of Ameri is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Laboratory Corporation of Ameri is Buy, with the following breakdown:
- Buy: 11
- Strong Buy: 7
- Hold: 6
- Sell: 0
- Strong Sell: 0
The Beta of Laboratory Corporation of Ameri is 1.1
The dividend of Laboratory Corporation of Ameri is $2.88
The dividend yield of Laboratory Corporation of Ameri is 0.0145000005%
The biggest institutional and mutual fund holders of Laboratory Corporation of Ameri stock are
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
- Wellington Management Group, LLP
The Laboratory Corporation of Ameri ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0